All Articles

Blue Mountain's new RAM Discover AI aims to revolutionize GMP asset management. But can it navigate the industry's complex regulatory maze?

While self-driving trucks grab headlines, the real supply chain revolution is happening in the yard. YMX Logistics is leading the charge.

A new Freeman report reveals attendees crave learning from peers and demos, not just lectures. This forces a radical rethink of event design and sponsorship.

Rio2 balances hard numbers with a social contract, releasing a bullish technical report for its Peruvian mine and a new ESG report for its Chilean project.

OWC's new Express 4M2 Ultra leverages Thunderbolt 5 to deliver blistering speeds for 12K video. Is this the future-proof investment studios have been waiting for?

Brazilian Rare Earths' massive discovery and savvy corporate split could be a game-changer for tech supply chains. But can it navigate the path to production?

Ladder Capital's Q2 shows a split verdict: a GAAP miss spooks the market, yet strong distributable earnings and loan growth reveal a resilient strategy.

Amidst market uncertainty, West Bancorporation's stellar Q2 results and record dividend showcase strategic prowess. But what do the details reveal?

As Orion Energy Systems preps its Q1 results, we look beyond the numbers at the real story: the second LED wave and the EV charging gold rush.

FrankCrum's record-breaking $271K donation to local nonprofits is more than charity; it's a blueprint for embedding community impact into corporate DNA.

A new strategic review uses golf to reveal a universal truth: your biggest growth opportunities may already exist within your current infrastructure.

A DOE-backed startup is using hybrid AI to predict severe storms weeks out. Success could save billions for insurance, energy, and agriculture sectors.

A Korean biotech is betting big on the U.S. market with its new GERD drug. A deal with manufacturer Bora Pharmaceuticals is the first step. Is it enough?

Following its acquisition by Kirin, Blackmores is launching a new brain supplement. This move tests the synergy and Kirin's big health science ambitions.

Tigunia's Spark division named a top ERP partner, highlighting a critical need for accessible, specialized financial tools for mission-driven organizations.

AcroCyte Therapeutics secures funding from the US government's 'DARPA for Health,' validating its unique organoid tech and signaling a strategic push to solve organ shortages.

AGI's new PTO-driven conveyor promises to move 9,000 bushels per hour with just a 60hp tractor. Is this the efficiency breakthrough farmers have been waiting for?

Sky Protocol posts another $100M+ revenue quarter, winning institutional trust while navigating market shocks and a strategic shift in stablecoin yields.

A new eBPF-powered platform promises to solve the networking nightmare of moving virtual machines to Kubernetes, paving the way for truly unified infrastructure.

With a billion people globally struggling with sleep apnea and CPAP compliance low, Incannex Healthcare is advancing its oral drug IHL-42X, now in a key Phase 2 study.